Literature DB >> 21287673

Thrombin generation in pediatric patients with Crohn's disease.

Heike Bernhard1, Andrea Deutschmann, Bettina Leschnik, Sabrina Schweintzger, Michael Novak, Almuthe Hauer, Wolfgang Muntean.   

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) have an increased risk of thromboembolic complications. The pathogenesis of IBD is not really clear and a high thrombin activity might contribute to the pathogenesis. We measured thrombin generation by means of calibrated automated thrombography (CAT), a new tool better reflecting overall hemostasis, in children with Crohn's disease (CD) during active and inactive disease and compared it to conventional markers of activity. We wanted to see whether children with CD have a higher potential for thrombin generation and if there is a correlation between hypercoagulability and disease activity.
METHODS: Plasma samples were collected from 22 patients with CD and from 61 healthy children. Thrombin generation was measured by means of CAT. The disease activity was estimated using the Pediatric Crohn's Disease Activity Index (PCDAI). In addition, F1+2, TAT, tissue factor pathway inhibitor (TFPI), fibrinogen, prothrombin (FII), antithrombin (AT), erythrocyte sedimentation rate (ESR), platelet count, α2-globulin, and orosomucoide were measured.
RESULTS: In all patients we found a significantly higher endogenous thrombin potential (ETP) and higher peak values during active disease. In accordance with this we also found significantly higher mean ETP values during active disease compared with the control group. We observed a significantly positive correlation between PCDAI and thrombin generation parameters.
CONCLUSIONS: Our study clearly shows that the active state of CD in children is associated with the potential for high thrombin generation, but this seems to be caused mainly by the inflammatory process and not by a preexisting propensity for high thrombin generation.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21287673     DOI: 10.1002/ibd.21631

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  12 in total

1.  Levels of TAFI, TFPI and ADAMTS-13 in inflammatory bowel disease.

Authors:  Bilgehan Yüzbaşıoğlu; Müge Ustaoğlu; Şule Yüzbaşıoğlu; Ulaş Emre Akbulut; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2019-12       Impact factor: 1.852

Review 2.  Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.

Authors:  Danuta Owczarek; Dorota Cibor; Mikołaj K Głowacki; Tomasz Rodacki; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 3.  Thromboembolic complications in inflammatory bowel disease.

Authors:  Darina Kohoutova; Paula Moravkova; Peter Kruzliak; Jan Bures
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

4.  Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.

Authors:  Hiroshi Takeyama; Tsunekazu Mizushima; Hideki Iijima; Shinzaki Shinichiro; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2015-06-16       Impact factor: 3.199

Review 5.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

6.  Thrombin mediates vagal apoptosis and dysfunction in inflammatory bowel disease.

Authors:  Danielle Fritze; Weizhen Zhang; Ji-Yao Li; Biaoxin Chai; Michael Mulholland
Journal:  J Gastrointest Surg       Date:  2014-06-11       Impact factor: 3.452

7.  Endoscopic activity, tissue factor and Crohn's disease: findings in clinical remission patients.

Authors:  Adriana Ribas Andrade; Tania Rubia Flores da Rocha; Carmen Lucia Ortiz-Agostinho; Iêda Nishitokukado; Alexandre Sousa Carlos; Matheus Freitas Cardoso de Azevedo; Claudio Lioshi Hashimoto; Aderson Omar Moura Cintra Damião; Flair José Carrilho; Elbio D'Amico; Aytan Miranda Sipahi; André Zonetti de Arruda Leite
Journal:  Therap Adv Gastroenterol       Date:  2020-08-03       Impact factor: 4.409

8.  Mean platelet volume: a controversial marker of disease activity in Crohn's disease.

Authors:  Song Liu; Jianan Ren; Gang Han; Gefei Wang; Guosheng Gu; Qiuyuan Xia; Jieshou Li
Journal:  Eur J Med Res       Date:  2012-10-12       Impact factor: 2.175

9.  Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.

Authors:  Ihosvany Fernández-Bello; Francisco J López-Longo; Elena G Arias-Salgado; Víctor Jiménez-Yuste; Nora V Butta
Journal:  Orphanet J Rare Dis       Date:  2013-05-27       Impact factor: 4.123

Review 10.  Creatine kinase in ischemic and inflammatory disorders.

Authors:  David Kitzenberg; Sean P Colgan; Louise E Glover
Journal:  Clin Transl Med       Date:  2016-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.